Anupam Rasayan India Ltd
Anupam Rasayan India Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #18 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
3 of 5 strong
The short version
Organic revenue growth expected at around 25% ± a couple of percentage points annually. - Addition of Jayhawk's revenue contributes an incremental 10% to 15% growth, as Jayhawk was not included in previous years. - Overall growth from existing three companies (Anupam, Tanfac, Jayhawk) anticipated to be strong, with Jayhawk contributing approx. Organic revenue growth expected around 25% (+/- a few percentage points) for FY27 from existing companies (Anupam, Tanfac), plus an additional 10-15% growth from Jayhawk's inclusion.
From Anupam Rasayan India Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Organic revenue growth expected at around 25% ± a couple of percentage points annually.
- Addition of Jayhawk's revenue contributes an incremental 10% to 15% growth, as Jayhawk was not included in previous years.
- Overall growth from existing three companies (Anupam, Tanfac, Jayhawk) anticipated to be strong, with Jayhawk contributing approx. INR140-150 crores this quarter.
- Growth excluding Jayhawk was single-digit, reflecting a seasonal tepid Q1.
- Post-consummation of Bliss GVS Pharma acquisition, further growth expected by improving asset utilization from current ~30% to 60-70% over 2-3 years.
- Bliss integration will likely stimulate growth via combined sales and marketing efforts.
2 more points from Anupam Rasayan India Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Anupam Rasayan India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Major capex cycle for existing Anupam platform has been completed, with all major projects commissioned and operational. (Page 6)
- Future capex expected to be limited, primarily for repair, maintenance, repurposing, or new product introductions. (Page 9)
- Guided capex range for FY27 is approximately INR 70-80 crores, focused mainly on standalone business. (Page 9)
- Jayhawk is well capitalized, unlevered, and expected to fund its own capex for growth, repurposing, or replacements without Anupam's funding support, at least in near term. (Page 9)
2 more points from Anupam Rasayan India Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Anupam Rasayan India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The order book revenue for the last year was roughly around INR 400 crores.
- This revenue is expected to be significantly higher this year, contributing around 25% of total revenue.
- Going forward, the order book is anticipated to contribute around 30% of total revenue.
2 more points from Anupam Rasayan India Ltd's call on order book
Create a free account to keep reading this call
Anupam Rasayan India Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹636 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Anupam Rasayan India Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Anupam Rasayan India Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Anupam Rasayan India Ltd Q1 FY27 results?
Organic revenue growth expected at around 25% ± a couple of percentage points annually. - Addition of Jayhawk's revenue contributes an incremental 10% to 15% growth, as Jayhawk was not included in previous years. - Overall growth from existing three companies (Anupam, Tanfac, Jayhawk) anticipated to be strong, with Jayhawk contributing approx. Organic revenue growth expected around 25% (+/- a few percentage points) for FY27 from existing companies (Anupam, Tanfac), plus an additional 10-15% growth from Jayhawk's inclusion.
What is Anupam Rasayan India Ltd share price analysis?
Anupam Rasayan India Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 76.6 with a market cap of ₹13,389 Cr. Investors should review the full earnings analysis for detailed insights.
Is Anupam Rasayan India Ltd planning capital expenditure?
Major capex cycle for existing Anupam platform has been completed, with all major projects commissioned and operational.
Keep Anupam Rasayan India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.